Ligand Pharmaceuticals Incorporated logo
Ligand Pharmaceuticals Incorporated LGND
$ 114.84 0.79%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Ligand Pharmaceuticals Incorporated Financial Statements 2011-2024 | LGND

Annual Financial Statements Ligand Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.36 B 1.21 B 2.07 B 3 B 1.71 B 2.49 B 3.47 B 2.11 B 1.98 B 1.16 B 1.28 B 397 M 241 M

Shares

17.3 M 16.9 M 16.6 M 16.2 M 19 M 21.2 M 21 M 20.8 M 19.8 M 20.4 M 20.3 M 19.9 M 19.7 M

Historical Prices

78.5 72 125 185 87.8 118 158 106 100 56.9 61.9 20.1 12.4

Net Income

52.2 M -33.4 M 57.1 M -2.98 M 629 M 143 M 12.6 M -1.64 M 257 M 12 M 11.4 M -527 K 10.2 M

Revenue

131 M 196 M 242 M 164 M 120 M 251 M 141 M 109 M 71.9 M 64.5 M 49 M 31.4 M 30 M

Cost of Revenue

- - - - - 6.34 M 5.37 M 5.57 M - - - - -

Gross Profit

- - - - 109 M 245 M 136 M 103 M 66.1 M 55.4 M 43.2 M 27.8 M 25.1 M

Operating Income

11.9 M 3.04 M 104 M 37.5 M 807 M 164 M 68.1 M 43.9 M 27.3 M 19.6 M 14.9 M 193 K -878 K

Interest Expense

656 K 1.8 M 19.6 M 27.4 M 35.7 M 48.3 M 13.5 M 12.8 M 1.77 M 4.86 M 2.08 M 2.92 M 2.51 M

EBITDA

48.5 M 54.6 M 155 M 63.2 M 11.1 M 180 M 80.2 M 55.6 M 31 M 23.4 M 18.6 M 3.62 M 2.65 M

Operating Expenses

- - - - 115 M 81.4 M 67.7 M 58.5 M 37.8 M 34.7 M 27.3 M 26.9 M 25.3 M

General and Administrative Expenses

52.8 M 70.1 M 46.8 M 60 M 41.9 M 37.7 M 28.7 M 26.6 M 24.4 M 22.6 M 18 M 16.1 M 15 M

All numbers in USD currency

Quarterly Income Statement Ligand Pharmaceuticals Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

18.4 M 18 M 17.7 M 17.6 M 17.4 M 17.3 M 17.1 M 17 M 16.9 M 16.9 M 16.8 M 16.8 M 16.7 M 16.7 M 16.4 M 16.1 M 16.1 M 16.1 M 16.5 M 17.2 M 18.8 M 19.6 M 20.4 M 21.1 M 21.1 M 21.2 M 21.2 M 21.1 M 21.1 M 21.2 M 21.2 M 20.9 M 20.9 M 20.8 M 20.7 M 19.9 M 19.9 M 19.7 M 19.6 M 19.9 M 20.4 M 20.7 M 20.6 M 20.4 M 20.4 M 20.3 M 20.2 M 20 B 19.9 B 19.7 B 19.7 B 19.7 M 19.7 M 19.6 M 19.6 M

Net Income

-7.17 M -51.9 M 86.1 M - -10.3 M 2.29 M 41.9 M - 404 K -895 K -15.4 M - 13.7 M 30.7 M 18.1 M 5.76 M -6.7 M 22.1 M -24.1 M -7.36 M -15.3 M -14.4 M 666 M -42.5 M 67.4 M 73.2 M 45.3 M -42.5 M 67.4 M 73.2 M 45.3 M -3.12 M 1.05 M -6.17 M 6.61 M 6.34 M 199 M 23.6 M 754 K 7.06 M 1.28 M 1.59 M 2.1 M 1.87 M 1.96 M 6.09 M 1.5 M 1.06 M -194 K -2.53 M 1.13 M 4.69 M -4.18 M -422 K 9.62 M

Revenue

51.8 M 41.5 M 31 M - 32.9 M 26.4 M 44 M - 59.2 M 50.1 M 36.5 M - 64.8 M 84.7 M 55.2 M 70 M 41.8 M 41.4 M 33.2 M 27 M 24.8 M 25 M 43.5 M 59.6 M 45.7 M 90 M 56.2 M 50.5 M 33.4 M 28 M 29.3 M 38.2 M 21.6 M 19.5 M 29.6 M 21.2 M 17.7 M 18.4 M 14.6 M 23 M 15 M 10.6 M 16 M 14.7 M 13 M 9.58 M 11.7 M 13.6 M 6.38 M 5.74 M 5.64 M 12.9 M 5.74 M 7.46 M 3.9 M

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - 3.15 M 2.4 M 3.86 M - 1.46 M 1.13 M 788 K - 2.38 M 903 K - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

3.14 M -19.1 M 2.99 M - 3.08 M -1.98 M 14.2 M - 12.3 M 8.66 M 2.13 M - 15.7 M 45.7 M 4.72 M - 3.75 M 7.1 M 3.79 M - -5.16 M -4.13 M 827 M - 23.4 M 70.2 M 37 M - 16.5 M 13 M 10.2 M - 5.47 M 3.97 M 15.1 M - 8.6 M 4.36 M 3.35 M - 3.53 M 1.36 M 5.1 M - 3.07 M 1.51 M 3.93 M - -1.42 M -1.82 M -839 K - -3.25 M -810 K -1.48 M

Interest Expense

-12.5 M -33.5 M 141 K - -4.3 M -873 K 240 K - 332 K 438 K 789 K - 4.44 M 4.88 M 5.83 M - 6.27 M 6.21 M 8.55 M - 8.99 M 9.01 M 8.91 M - 11.2 M 13.5 M 3.48 M - 3.39 M 3.34 M 2.94 M - 3.12 M 3.05 M 3 M - 2.93 M 2.97 M 2.97 M - 1.52 M 181 K 248 K - 394 K 453 K 912 K - 735 K 762 K 701 K - 699 K 674 K 423 K

EBITDA

- - 11.8 M - - - 23.7 M - 52.7 M 35.6 M 15.8 M - 53.6 M 70.9 M 17.3 M - 16.4 M 15 M 7.21 M - 6.49 M 3.57 M 830 M - 34.8 M 76.2 M 40 M - 24.1 M 18.6 M 13.2 M - 13.8 M 9.36 M 17.7 M - 9.24 M 5 M 4 M - 4.19 M 2.03 M 5.77 M - 3.74 M 2.18 M 4.6 M - -787 K -1.14 M -161 K - -2.51 M 539 K -919 K

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

24.5 M 17.6 M 11 M - 14.7 M 11.3 M 10.9 M - 14.9 M 12.1 M 11.9 M - 12.7 M 14.7 M 12.6 M - 15 M 10.1 M 9.26 M - 9.52 M 11 M 11.1 M - 9.63 M 9.29 M 7.64 M - 7.03 M 6.55 M 7.32 M - 6.55 M 7.24 M 7.07 M - 4.97 M 7.22 M 5.99 M - 6.74 M 5.24 M 5.07 M - 4.76 M 4.31 M 4.5 M - 4.31 M 3.86 M 3.42 M - 3.96 M 3.86 M 3.44 M

All numbers in USD currency